Chronic Total Occlusion Crossing With the Ocelot System - CONNECT II

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Total Atherosclerotic Occlusion of Femoral Artery
Interventions
DEVICE

CTO crossing in femoropopliteal arteries CONNECT II

CTO crossing in femoropopliteal arteries using the Ocelot System

Trial Locations (17)

10032

Columbia University Medical Center, New York

19010

Bryn Mawr Hospital, Bryn Mawr

30035

Mirano Hospital, Mirano

39216

St. Dominic Hospital, Jackson

43606

Jobst Vascular Center, Toledo

46802

St. Joseph's Hospital, Fort Wayne

48145

Muenster Hospital, Münster

48201

Detroit Medical Center, Detroit

48236

St. John Hospital and Medical Center, Detroit

60007

Cardiovascular Associates - Alexian Brothers Medical Center, Elk Grove Village

72211

Arkansas Heart Hospital, Little Rock

75093

The Heart Hospital Baylor Plano, Plano

78756

Austin Heart, Austin

79902

El Paso Cardiology Associates, El Paso

95619

Sutter Memorial, Sacramento

08015

Deborah Heart and Lung Center, Browns Mills

04289

Leipzig Hospital, Leipzig

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Avinger, Inc.

INDUSTRY

NCT01537302 - Chronic Total Occlusion Crossing With the Ocelot System - CONNECT II | Biotech Hunter | Biotech Hunter